Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Autoimmune Disorders

  Free Subscription


18.03.2019

1 Ann Neurol
1 Diabetes Res Clin Pract
4 J Autoimmun
2 J Clin Endocrinol Metab
2 J Neuroimmunol
2 J Neurol
4 J Pediatr Endocrinol Metab
4 J Rheumatol
1 Kidney Int
1 Nat Rev Neurol
1 Neurol Clin Pract
7 Neurology
1 PLoS Genet
4 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Neurol

  1. CREE BAC, Hollenbach JA, Bove R, Kirkish G, et al
    Silent Progression in Disease Activity-Free Relapsing Multiple Sclerosis.
    Ann Neurol. 2019 Mar 9. doi: 10.1002/ana.25463.
    PubMed     Text format     Abstract available


    Diabetes Res Clin Pract

  2. URBANOVA J, Brunerova L, Broz J
    Heterogeneity of gestational diabetes - Do we take MODY into consideration as much as we should?
    Diabetes Res Clin Pract. 2019;148:268-269.
    PubMed     Text format    


    J Autoimmun

  3. XIAO N, Wei J, Xu S, Du H, et al
    cGAS activation causes lupus-like autoimmune disorders in a TREX1 mutant mouse model.
    J Autoimmun. 2019 Mar 11. pii: S0896-8411(19)30035.
    PubMed     Text format     Abstract available

  4. WENDEL S, Venhoff N, Frye BC, May AM, et al
    Successful treatment of extensive calcifications and acute pulmonary involvement in dermatomyositis with the Janus-Kinase inhibitor tofacitinib - A report of two cases.
    J Autoimmun. 2019 Mar 9. pii: S0896-8411(18)30742.
    PubMed     Text format     Abstract available

  5. BING SJ, Shemesh I, Chong WP, Horai R, et al
    AS101 ameliorates experimental autoimmune uveitis by regulating Th1 and Th17 responses and inducing Treg cells.
    J Autoimmun. 2019 Mar 7. pii: S0896-8411(19)30020.
    PubMed     Text format     Abstract available

  6. YAMAMOTO E, Jorgensen TN
    Immunological effects of vitamin D and their relations to autoimmunity.
    J Autoimmun. 2019 Mar 7. pii: S0896-8411(19)30033.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  7. VENNERI MA, Hasenmajer V, Fiore D, Sbardella E, et al
    Circadian Rhythm of Glucocorticoid Administration Entrains Clock Genes in Immune Cells: A DREAM Trial Ancillary Study.
    J Clin Endocrinol Metab. 2018;103:2998-3009.
    PubMed     Text format     Abstract available

  8. PARIANI N, Willis M, Muller I, Healy S, et al
    Alemtuzumab-induced thyroid dysfunction exhibits distinctive clinical and immunological features.
    J Clin Endocrinol Metab. 2018 Jun 6. pii: 5033322. doi: 10.1210/jc.2018-00359.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  9. AMMITZBOLL C, Bornsen L, Petersen ER, Oturai AB, et al
    Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation.
    J Neuroimmunol. 2019;330:90-95.
    PubMed     Text format     Abstract available

  10. CIERNY D, Michalik J, Dubovan P, Skerenova M, et al
    The association of rs703842 variants in CYP27B1 with multiple sclerosis susceptibility is influenced by the HLA-DRB1*15:01 allele in Slovaks.
    J Neuroimmunol. 2019;330:123-129.
    PubMed     Text format     Abstract available


    J Neurol

  11. AL-ANSARI A, Robertson NP
    Autoimmune encephalitis: frequency and prognosis.
    J Neurol. 2019 Mar 15. pii: 10.1007/s00415-019-09273.
    PubMed     Text format    

  12. FRAU J, Coghe G, Lorefice L, Fenu G, et al
    Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis.
    J Neurol. 2019 Mar 12. pii: 10.1007/s00415-019-09272.
    PubMed     Text format     Abstract available


    J Pediatr Endocrinol Metab

  13. BABU KLG, Subramaniam P, Kaje K
    Assessment of dental caries and gingival status among a group of type 1 diabetes mellitus and healthy children of South India - a comparative study.
    J Pediatr Endocrinol Metab. 2018;31:1305-1310.
    PubMed     Text format     Abstract available

  14. PUTAREK K, Banfic L, Pasalic M, Krnic N, et al
    Arterial stiffness as a measure of cardiovascular risk in obese adolescents and adolescents with diabetes type 1.
    J Pediatr Endocrinol Metab. 2018;31:1315-1323.
    PubMed     Text format     Abstract available

  15. BAYRAMOGLU E, Elmaogullari S, Sagsak E, Aycan Z, et al
    Evaluation of long-term follow-up and methimazole therapy outcomes of pediatric Graves' disease: a single-center experience.
    J Pediatr Endocrinol Metab. 2019.
    PubMed     Text format     Abstract available

  16. DOS SANTOS TJ, Passone CGB, Ybarra M, Ito SS, et al
    Pitfalls in the diagnosis of insulin autoimmune syndrome (Hirata's disease) in a hypoglycemic child: a case report and review of the literature.
    J Pediatr Endocrinol Metab. 2019.
    PubMed     Text format     Abstract available


    J Rheumatol

  17. TERRE A, Talbot A, Louvrier C, Picque JB, et al
    Monoclonal gammopathy, arthralgias, and recurrent fever syndrome: a new autoinflammatory syndrome?
    J Rheumatol. 2019 Mar 15. pii: jrheum.181204. doi: 10.3899/jrheum.181204.
    PubMed     Text format     Abstract available

  18. LI C, Yap DYH, Chan G, Wen YB, et al
    Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy showing Thrombotic Microangiopathy.
    J Rheumatol. 2019 Mar 15. pii: jrheum.180773. doi: 10.3899/jrheum.180773.
    PubMed     Text format     Abstract available

  19. WITCZAK BN, Hetlevik SO, Sanner H, Barth Z, et al
    Effect on Cardiac Function of Longstanding Juvenile-onset Mixed Connective Tissue Disease: A Controlled Study.
    J Rheumatol. 2019 Mar 15. pii: jrheum.180526. doi: 10.3899/jrheum.180526.
    PubMed     Text format     Abstract available

  20. DUMONT A, Parienti JJ, Delmas C, Boutemy J, et al
    Factors Associated with Relapse and Dependence to Glucocorticoids in Giant-Cell Arteritis.
    J Rheumatol. 2019 Mar 15. pii: jrheum.181127. doi: 10.3899/jrheum.181127.
    PubMed     Text format     Abstract available


    Kidney Int

  21. KRONBICHLER A, Jayne DRW
    ANCA Renal Risk Score: is prediction of end-stage renal disease at baseline possible?
    Kidney Int. 2018;94:1045-1047.
    PubMed     Text format     Abstract available


    Nat Rev Neurol

  22. FYFE I
    New rat model recapitulates disabling grey matter damage in multiple sclerosis.
    Nat Rev Neurol. 2019 Mar 14. pii: 10.1038/s41582-019-0168.
    PubMed     Text format    


    Neurol Clin Pract

  23. SANTOS E, Silva AM, Stroebel P, Marinho A, et al
    Signs heralding appearance of thymomas after extended thymectomy for myasthenia gravis.
    Neurol Clin Pract. 2019;9:48-52.
    PubMed     Text format     Abstract available


    Neurology

  24. LEWIS A, Galetta S
    Editors' note: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.
    Neurology. 2019;92:542.
    PubMed     Text format    

  25. KEARNEY H
    Reader response: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.
    Neurology. 2019;92:542-543.
    PubMed     Text format    

  26. BAR-OR A, Grove RA, Tolson JM, Derosier FJ, et al
    Author response: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.
    Neurology. 2019;92:543.
    PubMed     Text format    

  27. YEH EA, Eshaghi A
    Evolution of regional brain atrophy in children with multiple sclerosis: Gray matters.
    Neurology. 2019 Mar 13. pii: WNL.0000000000007254.
    PubMed     Text format    

  28. FOX RJ, Cosenza C, Cripps L, Ford P, et al
    A survey of risk tolerance to multiple sclerosis therapies.
    Neurology. 2019 Mar 13. pii: WNL.0000000000007245.
    PubMed     Text format     Abstract available

  29. DE MEO E, Meani A, Moiola L, Ghezzi A, et al
    Dynamic gray matter volume changes in pediatric multiple sclerosis: A 3.5-year MRI study.
    Neurology. 2019 Mar 13. pii: WNL.0000000000007267.
    PubMed     Text format     Abstract available

  30. KALINCIK T
    Effectiveness of oral multiple sclerosis therapies in clinical context.
    Neurology. 2019 Mar 15. pii: WNL.0000000000007300.
    PubMed     Text format    


    PLoS Genet

  31. CHI C, Shao X, Rhead B, Gonzales E, et al
    Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry.
    PLoS Genet. 2019;15:e1007808.
    PubMed     Text format     Abstract available


    PLoS One

  32. GRACIA F, Larreategui M, Rodriguez G, Benzadon A, et al
    Costs of multiple sclerosis in Panama from societal, patient perspectives and health-related quality of life.
    PLoS One. 2018;13:e0204681.
    PubMed     Text format     Abstract available

  33. TAKAHASHI A, Moriya K, Ohira H, Arinaga-Hino T, et al
    Health-related quality of life in patients with autoimmune hepatitis: A questionnaire survey.
    PLoS One. 2018;13:e0204772.
    PubMed     Text format     Abstract available

  34. KALKOWSKI L, Malysz-Cymborska I, Golubczyk D, Janowski M, et al
    MRI-guided intracerebral convection-enhanced injection of gliotoxins to induce focal demyelination in swine.
    PLoS One. 2018;13:e0204650.
    PubMed     Text format     Abstract available

  35. UGARTE-BERZAL E, Berghmans N, Boon L, Martens E, et al
    Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis.
    PLoS One. 2018;13:e0197944.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  36. XU Q, Jin X, Zheng M, Rohila D, et al
    Phosphatase PP2A is essential for TH17 differentiation.
    Proc Natl Acad Sci U S A. 2019;116:982-987.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: